Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dal-PLAQUE 2: Dalcetrapib in Coronary Artery Disease
NCT01059682Phase 3Terminated
- Sponsor
- Roche
- Start
- Jan 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of dalcetrapib in coronary artery disease (CAD), sponsored by Roche. Started Jan 2010; status: terminated.
02
Drugs
dalcetrapib
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01059682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01059682.